The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
4
- 1
Middlebrook, Robert G
Born in May 1958Individual (1 offspring)Officer2019-08-29 ~ nowOF - Director → CIF 0 - 2
Kulasi, Ziaf Ahmed
Individual (1 offspring)Officer2022-10-01 ~ nowOF - Secretary → CIF 0 - 3
Carlton, Mark Beresford Lewis
Born in May 1965Individual (1 offspring)Officer2016-07-29 ~ nowOF - Director → CIF 0 - 4One Marina Park Drive, One Marina Park Drive, Boston, Massachussetts, United StatesCorporate (1 offspring)Person with significant control2020-12-16 ~ nowPE - Has significant influence or control → CIF 0
Ceased
6
- 1
Sutcliffe, James Holden
Finance Director born in February 1967IndividualOfficer2016-07-29 ~ 2016-12-01OF - Director → CIF 0 - 2
Gasson, Michelle Sally-ann Albertine
IndividualOfficer2016-12-01 ~ 2018-01-12OF - Secretary → CIF 0 - 3
Berrigan, Sean Daniel
IndividualOfficer2018-04-12 ~ 2022-10-01OF - Secretary → CIF 0 - 4
Margus, Brad
Chief Executive born in June 1960IndividualOfficer2016-12-01 ~ 2019-08-29OF - Director → CIF 0 - 5Suite 1410, One Marina Park Drive, Boston, Ma, United StatesCorporatePerson with significant control2016-12-01 ~ 2020-12-16PE - Ownership of voting rights - 75% or more → CIF 0PE - Has significant influence or control as a member of a firm → CIF 0PE - Ownership of shares – 75% or more → CIF 0PE - Right to appoint or remove directors as a member of a firm → CIF 0
- 6
TAKEDA CAMBRIDGE LIMITED
- nowPARADIGM THERAPEUTICS LIMITED - 2007-03-30418 Cambridge Science Park, Milton Road, Cambridge, United KingdomActive Corporate (5 parents)Person with significant control2016-07-29 ~ 2016-11-30PE - Right to appoint or remove directors → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0PE - Ownership of shares – 75% or more → CIF 0PE - Has significant influence or control → CIF 0
Company in focus
CEREVANCE, LTD
Previous name
TAKEDA CAMBRIDGE NEUROSCIENCE LIMITED - 2016-12-06
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
462024-01-01 ~ 2024-12-31
432023-01-01 ~ 2023-12-31
Turnover/Revenue
15,165 GBP2024-01-01 ~ 2024-12-31
17,660 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-16,121 GBP2024-01-01 ~ 2024-12-31
-18,310 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
609 GBP2024-01-01 ~ 2024-12-31
533 GBP2023-01-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
5 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
609 GBP2024-01-01 ~ 2024-12-31
538 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
411 GBP2024-01-01 ~ 2024-12-31
-67 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment
667 GBP2024-12-31
691 GBP2023-12-31
Fixed Assets
667 GBP2024-12-31
691 GBP2023-12-31
Debtors
Current
4,962 GBP2024-12-31
4,021 GBP2023-12-31
Cash at bank and in hand
1,797 GBP2024-12-31
2,151 GBP2023-12-31
Current Assets
6,759 GBP2024-12-31
6,172 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-1,890 GBP2024-12-31
Net Current Assets/Liabilities
4,869 GBP2024-12-31
4,024 GBP2023-12-31
Net Assets/Liabilities
5,462 GBP2024-12-31
4,567 GBP2023-12-31
Equity
Called up share capital
1,000 GBP2024-12-31
1,000 GBP2023-12-31
1,000 GBP2023-01-01
Other miscellaneous reserve
2,470 GBP2024-12-31
1,986 GBP2023-12-31
1,651 GBP2023-01-01
Retained earnings (accumulated losses)
1,992 GBP2024-12-31
1,581 GBP2023-12-31
1,648 GBP2023-01-01
Equity
5,462 GBP2024-12-31
4,567 GBP2023-12-31
4,299 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
411 GBP2024-01-01 ~ 2024-12-31
-67 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-76 GBP2024-01-01 ~ 2024-12-31
402 GBP2023-01-01 ~ 2023-12-31
Tax Expense/Credit at Applicable Tax Rate
152 GBP2024-01-01 ~ 2024-12-31
126 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
2,504 GBP2024-12-31
2,252 GBP2023-12-31
Computers
134 GBP2024-12-31
130 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
2,713 GBP2024-12-31
2,457 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
1,581 GBP2023-12-31
Computers
110 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
1,766 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
259 GBP2024-01-01 ~ 2024-12-31
Computers, Owned/Freehold
21 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
280 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
1,840 GBP2024-12-31
Computers
131 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,046 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
664 GBP2024-12-31
671 GBP2023-12-31
Computers
3 GBP2024-12-31
20 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
1,597 GBP2024-12-31
2,098 GBP2023-12-31
Other Debtors
Current
2,373 GBP2024-12-31
1,019 GBP2023-12-31
Prepayments/Accrued Income
Current
854 GBP2024-12-31
742 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
138 GBP2024-12-31
162 GBP2023-12-31
Trade Creditors/Trade Payables
Current
1,035 GBP2024-12-31
1,520 GBP2023-12-31
Taxation/Social Security Payable
Current
108 GBP2024-12-31
329 GBP2023-12-31
Other Creditors
Current
3 GBP2024-12-31
30 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
744 GBP2024-12-31
269 GBP2023-12-31
Creditors
Current
1,890 GBP2024-12-31
2,148 GBP2023-12-31
Net Deferred Tax Liability/Asset
-74 GBP2024-12-31
-148 GBP2023-12-31
254 GBP2023-01-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
74 GBP2024-01-01 ~ 2024-12-31
-402 GBP2023-01-01 ~ 2023-12-31
Deferred Tax Liabilities
Accelerated tax depreciation
93 GBP2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1,000,000 shares2024-12-31
1,000,000 shares2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
531 GBP2024-12-31
531 GBP2023-12-31
Between one and five year
2,122 GBP2024-12-31
2,122 GBP2023-12-31
More than five year
663 GBP2024-12-31
1,282 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
3,316 GBP2024-12-31
3,935 GBP2023-12-31
CEREVANCE, LTD
InfoTAKEDA CAMBRIDGE NEUROSCIENCE LIMITED - 2016-12-06Registered number 10304008418 Cambridge Science Park Milton Road, Cambridge CB4 0PZPRIVATE LIMITED COMPANY incorporated on 2016-07-29 (9 years 6 months). The company status is Active.The last date of confirmation statement was made at 2024-07-28CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 9 February 2026 and
licensed under the Open Government Licence v3.0.